Swiss National Bank’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-152,900
| Closed | -$3.08M | – | 2766 |
|
|
2021
Q3 | $3.08M | Buy |
152,900
+4,000
| +3% | +$80.6K | ﹤0.01% | 1765 |
|
|
2021
Q2 | $5.56M | Buy |
148,900
+3,200
| +2% | +$119K | ﹤0.01% | 1434 |
|
|
2021
Q1 | $3.73M | Buy |
145,700
+2,600
| +2% | +$66.5K | ﹤0.01% | 1642 |
|
|
2020
Q4 | $3.15M | Buy |
143,100
+700
| +0.5% | +$15.4K | ﹤0.01% | 1648 |
|
|
2020
Q3 | $2.56M | Buy |
142,400
+2,500
| +2% | +$45K | ﹤0.01% | 1593 |
|
|
2020
Q2 | $3.55M | Buy |
139,900
+40,400
| +41% | +$1.03M | ﹤0.01% | 1355 |
|
|
2020
Q1 | $1.83M | Buy |
99,500
+1,400
| +1% | +$25.7K | ﹤0.01% | 1511 |
|
|
2019
Q4 | $2.16M | Buy |
98,100
+1,900
| +2% | +$41.9K | ﹤0.01% | 1687 |
|
|
2019
Q3 | $1.38M | Buy |
96,200
+8,600
| +10% | +$123K | ﹤0.01% | 1884 |
|
|
2019
Q2 | $1.38M | Buy |
87,600
+7,600
| +10% | +$120K | ﹤0.01% | 1933 |
|
|
2019
Q1 | $1.17M | Buy |
80,000
+4,500
| +6% | +$65.9K | ﹤0.01% | 1984 |
|
|
2018
Q4 | $807K | Buy |
75,500
+10,000
| +15% | +$107K | ﹤0.01% | 2124 |
|
|
2018
Q3 | $1M | Buy |
65,500
+11,400
| +21% | +$174K | ﹤0.01% | 2141 |
|
|
2018
Q2 | $663K | Buy |
+54,100
| New | +$663K | ﹤0.01% | 2363 |
|